Works by Amara, Alieu
Results: 21
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 11, p. 2, doi. 10.2807/1560-7917.ES.2023.28.11.2300135
- By:
- Publication type:
- Article
Improving health information systems during an emergency: lessons and recommendations from an Ebola treatment centre in Sierra Leone.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Development and Deployment of the OpenMRS-Ebola Electronic Health Record System for an Ebola Treatment Center in Sierra Leone.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults.
- Published in:
- AIDS Research & Treatment, 2012, p. 1, doi. 10.1155/2012/105980
- By:
- Publication type:
- Article
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, n. 1, p. 149, doi. 10.1093/jac/dky384
- By:
- Publication type:
- Article
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39).
- Published in:
- Journal of NeuroVirology, 2018, v. 24, n. 4, p. 391, doi. 10.1007/s13365-018-0626-4
- By:
- Publication type:
- Article
The development and validation of a novel LC–MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
- Published in:
- Biomedical Chromatography, 2020, v. 34, n. 1, p. N.PAG, doi. 10.1002/bmc.4711
- By:
- Publication type:
- Article
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e525, doi. 10.1093/cid/ciac199
- By:
- Publication type:
- Article
Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 5, p. e1200, doi. 10.1093/cid/ciaa1861
- By:
- Publication type:
- Article
Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 3, p. 453, doi. 10.1093/cid/civ317
- By:
- Publication type:
- Article
Cerebrospinal Fluid Exposure of Efavirenz and Its Major Metabolites When Dosed at 400 mg and 600 mg Once Daily: A Randomized Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 7, p. 1026, doi. 10.1093/cid/ciu976
- By:
- Publication type:
- Article
An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 585, doi. 10.1002/cpt.2463
- By:
- Publication type:
- Article